BZ1
(+)-4-ETHYLAMINO-3,4-DIHYDRO-2-(METHOXY)PROPYL-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE
| Created: | 1999-07-08 |
| Last modified: | 2021-03-01 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 44 |
| Chiral Atom Count | 1 |
| Bond Count | 45 |
| Aromatic Bond Count | 5 |
Chemical Component Summary | |
|---|---|
| Name | (+)-4-ETHYLAMINO-3,4-DIHYDRO-2-(METHOXY)PROPYL-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE |
| Synonyms | Brinzolamide |
| Systematic Name (OpenEye OEToolkits) | (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-bis(oxidanylidene)-3,4-dihydrothieno[3,2-e][1,2]thiazine-6-sulfonamide |
| Formula | C12 H21 N3 O5 S3 |
| Molecular Weight | 383.507 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | O=S(=O)(c1sc2c(c1)C(NCC)CN(S2(=O)=O)CCCOC)N |
| SMILES | CACTVS | 3.385 | CCN[CH]1CN(CCCOC)[S](=O)(=O)c2sc(cc12)[S](N)(=O)=O |
| SMILES | OpenEye OEToolkits | 1.7.6 | CCNC1CN(S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)CCCOC |
| Canonical SMILES | CACTVS | 3.385 | CCN[C@H]1CN(CCCOC)[S](=O)(=O)c2sc(cc12)[S](N)(=O)=O |
| Canonical SMILES | OpenEye OEToolkits | 1.7.6 | CCN[C@H]1CN(S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)CCCOC |
| InChI | InChI | 1.03 | InChI=1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1 |
| InChIKey | InChI | 1.03 | HCRKCZRJWPKOAR-JTQLQIEISA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB01194 |
|---|---|
| Name | Brinzolamide |
| Description | Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor. Carbonic anhydrase (CA) is an enzyme found in many tissues of the body including the eye. It catalyzes the reversible reaction involving the hydration of carbon dioxide and the dehydration of carbonic acid. In humans, carbonic anhydrase exists as a number of isoenzymes, the most active being carbonic anhydrase II (CA-II). Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. The result is a reduction in intraocular pressure. Brinzolamide is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. |
| Synonyms |
|
| Indication | For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. |
| Categories |
|
| ATC-Code |
|
| CAS number | 138890-62-7 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Carbonic anhydrase 2 | MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS... | unknown | inhibitor |
| Carbonic anhydrase 1 | MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISV... | unknown | inhibitor |
| Carbonic anhydrase 4 | MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKWGGNCQKDR... | unknown | inhibitor |
| Carbonic anhydrase 5A, mitochondrial | MLGRNTWKTSAFSFLVEQMWAPLWSRSMRPGRWCSQRSCAWQTSNNTLHP... | unknown | inhibitor |
| Carbonic anhydrase 3 | MAKEWGYASHNGPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVS... | unknown | inhibitor |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL220491 |
| PubChem | 68844 |
| ChEMBL | CHEMBL220491 |
| ChEBI | CHEBI:3176 |
| CCDC/CSD | AKOFUD |
| COD | 2241650 |














